Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells

Molecular Biology Reports

Volumn 37, Issue 4, 2010, Pages 1971-1977

  Wang, Lili ^a   Xue, Lexun ^a,b   Yan, Hongxia ^b   Li, Jie ^b   Lu, Yucheng ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Adhesion; Esophageal squamous cell cancer; Motility; Rho associated protein kinase; Y 27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACTIN; COFILIN; RHO KINASE; UVOMORULIN; AMIDE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; ESOPHAGUS TUMOR; HUMAN; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

AMIDES; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; ESOPHAGEAL NEOPLASMS; HUMANS; PROTEIN KINASE INHIBITORS; PYRIDINES; RHO-ASSOCIATED KINASES;

EID: 77953155101     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9645-9     Document Type: Article

References (35)

1. Ortíz-López L, Morales-Mulia S, Ramírez- Rodríguez G, Benítez- King G (2009) ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res 46:15-21
2. Leve F, de Souza W, Morgado-Díaz JA (2008) A cross-link between protein kinase A and Rho-family GTPases signaling mediates cell-cell adhesion and actin cytoskeleton organization in epithelial cancer cells. J Pharmacol Exp Ther 327:777-788
3. Lawler K, Foran E, O'Sullivan G, Long A, Kenny D (2006) Mobility and invasiveness of metastatic esophageal cancer are potentiated by shear stress in a ROCK- and Ras-dependent manner. Am J Physiol Cell Physiol 291:C668-C677
4. Nakagawa H, Yoshioka K, Miyahara E, Fukushima Y, Tamura M, Itoh K (2005) Intrathecal administration of Y-27632, a specific Rho-associated kinase inhibitor, for rat neoplastic meningitis. Mol Cancer Res 3:425-433
5. Shimada T, Nishimura Y, Nishiuma T, Rikitake Y, Hirase T, Yokoyama M (2007) Adenoviral transfer of rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic change. Kobe J Med Sci 53:125-134
6. Rösel D, Brábek J, Tolde O, Mierke CT, Zitterbart DP, Raupach C, Bicanová K, Kollmannsberger P, Panková D, Vesely P, Folk P, Fabry B (2008) Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res 6:1410-1420
7. Xue F, Takahara T, Yata Y, Xia Q, Nonome K, Shinno E, Kanayama M, Takahara S, Sugiyama T (2008) Blockade of Rho/ Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase- dependent manner. Hepatol Res 38:810-817
8. Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, Guzman G, Cho M, Glover SC (2007) ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 87:1149-1158
9. Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG (2008) The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol 33:585-593
10. Papadopoulou N, Charalampopoulos I, Alevizopoulos K, Gravanis A, Stournaras C (2008) Rho/ROCK/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells. Exp Cell Res 314:3162-3174
11. Ordóñez-Morán P, Larriba MJ, Pálmer HG, Valero RA, Barba ́chano A, Duñach M, de Herreros AG, Villalobos C, Berciano MT, Lafarga M, Muñoz A (2008) RhoA-ROCK and p38MAPKMSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J Cell Biol 183:697-710
12. Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M, Ingber DE (2008) Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci USA 105:11305-11310
13. Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC (2005) p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 218:69-79
14. Whibley CE, Keyzers RA, Soper AG, Davies-Coleman MT, Samaai T, Hendricks DT (2005) Antiesophageal cancer activity from Southern African marine organisms. AnnNYAcad Sci 1056: 405-412
15. Montesano R, Hollstein M, Hainaut P (1996) Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review. Int J Cancer 69:225-235
16. 2+ sensitization. Am J Respir Cell Mol Biol 20:1190-1200
17. Tian F, Zang WD, Hou WH, Liu HT, Xue LX (2006) Nuclear factor-jB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin 38: 318-326
18. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
19. Hou GQ, Xue LX, Lu ZM, Fan TL, Tian F, Xue YL (2007) An activated mTOR/p70S6 K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Cancer Lett 253:236-248
20. Wang SM, Zhu J, Pan LF, Liu YK (2008) Inhibitory effect of dimeric β peptide on the recurrence and metastasis of hepatocellular carcinoma in vitro and in mice. World J Gastroenterol 14:3054-3058
21. Park TY, Park MH, Shin WC, Rhee MH, Seo DW, Cho JY, Kim HM (2008) Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol Pharm Bull 31:1802-1805
22. Meyer-Ter-Vehn T, Gebhardt S, Sebald W, Buttmann M, Grehn F, Schlunck G, Knaus P (2006) p38 inhibitors prevent TGF-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 47:1500-1509 (Pubitemid 46780758)
23. Li Q, Mattingly RR (2008) Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells. Neoplasia 10:1444-1458
24. Muise AM, Walters TD, Glowacka WK, Griffiths AM, Ngan BY, Lan H, Xu W, Silverberg M, Rotin D (2009) Polymorphisms in E-cadherin (CDH1) result in a mis-localized cytoplasmic protein that is associated with Crohn's Disease. Gut 58:1121-1127
25. Molina-Ortiz I, Bartolomé RA, Hernández-Varas P, Colo GP, Teixidó J (2009) Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/ p120ctn-dependent inactivation of RhoA. J Biol Chem 284:15147-15157
26. Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ, Du H, Zhang GG, Hu Y, Lu AP, Li JY, Ji JF (2008) Positive association of upregulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology 52:560-568
27. Pyo SW, Hashimoto M, Kim YS, Kim CH, Lee SH, Johnson KR, Wheelock MJ, Park JU (2007) Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: Correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg 35:1-9
28. Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY (2008) Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas. World J Gastroenterol 14:5665-5673
29. Filenius S, Tervo T, Virtanen I (2003) Production of fibronectin and tenascin isoforms and their role in the adhesion of human immortalized corneal epithelial cells. Invest Ophthalmol Vis Sci 44:3317-3325
30. Imamura F, Mukai M, Ayaki M, Akedo H (2000) Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase. Jpn J Cancer Res 91:811-816
31. Han S, Ritzenthaler JD, Sitaraman SV, Roman J (2006) Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281:29614-29624
32. Gill KS, Beier F, Goldberg HA (2008) Rho-ROCK signaling differentially regulates chondrocyte spreading on fibronectin and bone sialoprotein. Am J Physiol Cell Physiol 295:C38-C49
33. Honjo M, Tanihara H, Kameda T, Kawaji T, Yoshimura N, Araie M (2007) Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery. Invest Ophthalmol Vis Sci 48:5549-5557
34. Jiang P, Enomoto A, Takahashi M (2009) Cell biology of the movement of breast cancer cells: Intracellular signalling and the actin cytoskeleton. Cancer Lett. doi:10.1016/j.canlet.2009.02.034
35. Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE, Condeelis JS (2005) Tumor cells caught in the act of invading: Their strategy for enhanced cell motility. Trends Cell Biol 15:138-145